- Home
- LW vs MRNA Comparison
LW vs MRNA Comparison
Compare LW & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LW
- MRNA
- Stock Information
- Founded
- LW 1950
- MRNA 2010
- Country
- LW United States
- MRNA United States
- Employees
- LW N/A
- MRNA N/A
- Industry
- LW Packaged Foods
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LW Consumer Staples
- MRNA Health Care
- Exchange
- LW Nasdaq
- MRNA Nasdaq
- Market Cap
- LW 9.0B
- MRNA 9.8B
- IPO Year
- LW N/A
- MRNA 2018
- Fundamental
- Price
- LW $62.96
- MRNA $24.52
- Analyst Decision
- LW Buy
- MRNA Hold
- Analyst Count
- LW 10
- MRNA 15
- Target Price
- LW $69.40
- MRNA $37.15
- AVG Volume (30 Days)
- LW 1.9M
- MRNA 8.5M
- Earning Date
- LW 12-18-2025
- MRNA 11-06-2025
- Dividend Yield
- LW 2.34%
- MRNA N/A
- EPS Growth
- LW N/A
- MRNA N/A
- EPS
- LW 2.08
- MRNA N/A
- Revenue
- LW $6,456,500,000.00
- MRNA $3,078,000,000.00
- Revenue This Year
- LW $4.12
- MRNA N/A
- Revenue Next Year
- LW N/A
- MRNA $11.12
- P/E Ratio
- LW $30.41
- MRNA N/A
- Revenue Growth
- LW 0.00
- MRNA N/A
- 52 Week Low
- LW $47.87
- MRNA $23.15
- 52 Week High
- LW $83.98
- MRNA $57.69
- Technical
- Relative Strength Index (RSI)
- LW 51.09
- MRNA 39.59
- Support Level
- LW $62.69
- MRNA $25.57
- Resistance Level
- LW $67.07
- MRNA $27.37
- Average True Range (ATR)
- LW 1.34
- MRNA 1.14
- MACD
- LW -0.45
- MRNA -0.32
- Stochastic Oscillator
- LW 9.86
- MRNA 6.38
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.